A new trading day began on Friday, with Roivant Sciences Ltd (NASDAQ: ROIV) stock price up 6.01% from the previous day of trading, before settling in for the closing price of $11.82. ROIV’s price has ranged from $8.61 to $13.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 493.24% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -113.38%. With a float of $377.26 million, this company’s outstanding shares have now reached $806.68 million.
In an organization with 908 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 88.77%, operating margin of 3447.71%, and the pretax margin is 3781.64%.
Roivant Sciences Ltd (ROIV) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Roivant Sciences Ltd is 48.18%, while institutional ownership is 67.69%. The most recent insider transaction that took place on Nov 20 ’24, was worth 1,132,000. In this transaction President & COO of this company sold 100,000 shares at a rate of $11.32, taking the stock ownership to the 606,525 shares. Before that another transaction happened on Nov 20 ’24, when Company’s Officer proposed sale 100,000 for $11.32, making the entire transaction worth $1,132,008.
Roivant Sciences Ltd (ROIV) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.21 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -113.38% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Here are Roivant Sciences Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 76.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.66, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -1.04 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Let’s dig in a bit further. During the last 5-days, its volume was 6.07 million. That was better than the volume of 5.86 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 70.29%. Additionally, its Average True Range was 0.35.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 82.82%, which indicates a significant decrease from 97.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.61% in the past 14 days, which was higher than the 28.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.69, while its 200-day Moving Average is $11.22. However, in the short run, Roivant Sciences Ltd’s stock first resistance to watch stands at $12.81. Second resistance stands at $13.08. The third major resistance level sits at $13.60. If the price goes on to break the first support level at $12.02, it is likely to go to the next support level at $11.50. The third support level lies at $11.23 if the price breaches the second support level.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
With a market capitalization of 9.67 billion, the company has a total of 739,522K Shares Outstanding. Currently, annual sales are 124,800 K while annual income is 4,349 M. The company’s previous quarter sales were 4,480 K while its latest quarter income was -230,180 K.
